Pen or syringe? study tests best way to deliver drug
NCT ID NCT06946524
First seen Nov 01, 2025 · Last updated May 14, 2026 · Updated 29 times
Summary
This study tested how well risankizumab enters the body when given by a prefilled pen compared to a standard syringe. Fifty-nine healthy adults received the drug one way or the other, and researchers measured drug levels in the blood and watched for side effects. The goal was to see if the pen works as well as the syringe, which could make future injections easier for patients.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY VOLUNTEERS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Acpru /Id# 275116
Grayslake, Illinois, 60030, United States
-
Altasciences Clinical Los Angeles /ID# 276446
Cypress, California, 90630, United States
Conditions
Explore the condition pages connected to this study.